San Diego-based Illumina, a global leader in genomic sequencing technology ... the industry alongside the company with every product launch. That turning point is one of the reasons it was ...

which is a competitor to Illumina technology, like its mid-range NextSeq 2000 sequencer, and the forthcoming launch of Aviti24 that combines sequencing and cell characteristic mapping in a single ...

Gene sequencing machine maker Illumina forecast 2025 revenue largely below Wall Street estimates on Thursday, signaling ...

The IMCore of the UW Sensory Biology Center is pleased to announce the availability of an Illumina NextSeq 1000 sequencer. This equipment is purchased exclusively via an administrative supplement ...

Researchers from Eclypsium analyzed the BIOS firmware in iSeq 100, a DNA sequencer built by a US biotechnology company Illumina ... Threat actors could launch LogoFAIL, Spectre 2, and ...

Illumina recently launched the MiSeq i100 and MiSeq i100 Plus Systems, two powerful, compact benchtop sequencers that incorporate more than 140 invention disclosures and 60 patent families.

The placement of Illumina in China's unreliable entity list could have disruptive implications. Read why I remain bullish on ...

The genomics industry is set for growth due to advancements in personalized medicine, diagnostics, and biotech innovations.

Illumina's (ILMN) stock slid 5% post-market after it released its Q4 earnings report and reiterated its 2025 guidance, ...

Shares of gene-sequencing leader Illumina have fallen 15% from Friday. Rivals 10X Genomics and Pacific BioSciences of California lost 18% and 15%, respectively. We recently published a list of Jim ...

[1] Examples are platforms developed by companies such as Roche Applied Science (454 Genome Sequencer FLX [GS FLX] System; CT, USA), Illumina (Genome Analyzer [GA] II; CA, USA), Life Technologies ...